Assessing the long-term role of L-type voltage dependent calcium channel blocker verapamil on short-term presynaptic plasticity at dentate gyrus of hippocampus. 2007

Reza Lashgari, and Fereshteh Motamedi, and Seyed-Mohammad Noorbakhsh, and Saleh Zahedi-Asl, and Alireza Komaki, and Siamak Shahidi, and Abbas Haghparast
Neuroscience Research Center and Department of Physiology, Shaheed Beheshti University of Medical Sciences, Tehran, Iran. rezalashgari@ipm.ir

High-voltage-activated Ca(2+) channels on presynaptic nerve terminals are known to play an important role in neurotransmitter release at both excitatory and inhibitory synapses. Whereas there is currently debate over the contribution of L-type voltage dependent Ca(2+) channels (L-type VDCCs) on the short-term presynaptic plasticity which is a defining feature of neuronal activity, the underlying mechanisms are poorly understood. In the present study, the L-type VDCCs chronically was inhibited with different doses of verapamil (10, 20 and 50 mg/kg; orally) to evaluate hippocampal dentate gyrus (DG) inhibitory interneuron function and its involvement on short-term plasticity using paired pulse stimulation in perforant path-DG of hippocampus. Our data show that chronic oral treatment of verapamil at dose of 50 mg/kg but not at lower doses, facilitated the excitability of DG cells at inter-stimulus intervals 20, 30 and 50 ms (P<0.03, 0.01 and 0.001; respectively) in population spike amplitude ratio, which is indicative of paired pulse potentiation in perforant path-DG synapses. While there are no significant differences in field excitatory postsynaptic potential slope ratio at all doses. We suggest that DG neurons facilitation is caused by inhibition of inhibitory interneurons directly and/or indirectly via inhibition of glutamate release in hippocampal DG. Therefore, these experiments indicate that chronic use of verapamil has effect on short-term presynaptic plasticity.

UI MeSH Term Description Entries
D008297 Male Males
D009473 Neuronal Plasticity The capacity of the NERVOUS SYSTEM to change its reactivity as the result of successive activations. Brain Plasticity,Plasticity, Neuronal,Axon Pruning,Axonal Pruning,Dendrite Arborization,Dendrite Pruning,Dendritic Arborization,Dendritic Pruning,Dendritic Remodeling,Neural Plasticity,Neurite Pruning,Neuronal Arborization,Neuronal Network Remodeling,Neuronal Pruning,Neuronal Remodeling,Neuroplasticity,Synaptic Plasticity,Synaptic Pruning,Arborization, Dendrite,Arborization, Dendritic,Arborization, Neuronal,Arborizations, Dendrite,Arborizations, Dendritic,Arborizations, Neuronal,Axon Prunings,Axonal Prunings,Brain Plasticities,Dendrite Arborizations,Dendrite Prunings,Dendritic Arborizations,Dendritic Prunings,Dendritic Remodelings,Network Remodeling, Neuronal,Network Remodelings, Neuronal,Neural Plasticities,Neurite Prunings,Neuronal Arborizations,Neuronal Network Remodelings,Neuronal Plasticities,Neuronal Prunings,Neuronal Remodelings,Neuroplasticities,Plasticities, Brain,Plasticities, Neural,Plasticities, Neuronal,Plasticities, Synaptic,Plasticity, Brain,Plasticity, Neural,Plasticity, Synaptic,Pruning, Axon,Pruning, Axonal,Pruning, Dendrite,Pruning, Dendritic,Pruning, Neurite,Pruning, Neuronal,Pruning, Synaptic,Prunings, Axon,Prunings, Axonal,Prunings, Dendrite,Prunings, Dendritic,Prunings, Neurite,Prunings, Neuronal,Prunings, Synaptic,Remodeling, Dendritic,Remodeling, Neuronal,Remodeling, Neuronal Network,Remodelings, Dendritic,Remodelings, Neuronal,Remodelings, Neuronal Network,Synaptic Plasticities,Synaptic Prunings
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014700 Verapamil A calcium channel blocker that is a class IV anti-arrhythmia agent. Iproveratril,Calan,Cordilox,Dexverapamil,Falicard,Finoptin,Isoptin,Isoptine,Izoptin,Lekoptin,Verapamil Hydrochloride,Hydrochloride, Verapamil
D017729 Presynaptic Terminals The distal terminations of axons which are specialized for the release of neurotransmitters. Also included are varicosities along the course of axons which have similar specializations and also release transmitters. Presynaptic terminals in both the central and peripheral nervous systems are included. Axon Terminals,Nerve Endings, Presynaptic,Synaptic Boutons,Synaptic Terminals,Axon Terminal,Bouton, Synaptic,Boutons, Synaptic,Ending, Presynaptic Nerve,Endings, Presynaptic Nerve,Nerve Ending, Presynaptic,Presynaptic Nerve Ending,Presynaptic Nerve Endings,Presynaptic Terminal,Synaptic Bouton,Synaptic Terminal,Terminal, Axon,Terminal, Presynaptic,Terminal, Synaptic,Terminals, Axon,Terminals, Presynaptic,Terminals, Synaptic

Related Publications

Reza Lashgari, and Fereshteh Motamedi, and Seyed-Mohammad Noorbakhsh, and Saleh Zahedi-Asl, and Alireza Komaki, and Siamak Shahidi, and Abbas Haghparast
February 1994, Neuroscience letters,
Reza Lashgari, and Fereshteh Motamedi, and Seyed-Mohammad Noorbakhsh, and Saleh Zahedi-Asl, and Alireza Komaki, and Siamak Shahidi, and Abbas Haghparast
May 1998, Neurobiology of learning and memory,
Reza Lashgari, and Fereshteh Motamedi, and Seyed-Mohammad Noorbakhsh, and Saleh Zahedi-Asl, and Alireza Komaki, and Siamak Shahidi, and Abbas Haghparast
July 2009, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Reza Lashgari, and Fereshteh Motamedi, and Seyed-Mohammad Noorbakhsh, and Saleh Zahedi-Asl, and Alireza Komaki, and Siamak Shahidi, and Abbas Haghparast
January 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Reza Lashgari, and Fereshteh Motamedi, and Seyed-Mohammad Noorbakhsh, and Saleh Zahedi-Asl, and Alireza Komaki, and Siamak Shahidi, and Abbas Haghparast
January 2005, Hippocampus,
Reza Lashgari, and Fereshteh Motamedi, and Seyed-Mohammad Noorbakhsh, and Saleh Zahedi-Asl, and Alireza Komaki, and Siamak Shahidi, and Abbas Haghparast
July 2001, Proceedings of the National Academy of Sciences of the United States of America,
Reza Lashgari, and Fereshteh Motamedi, and Seyed-Mohammad Noorbakhsh, and Saleh Zahedi-Asl, and Alireza Komaki, and Siamak Shahidi, and Abbas Haghparast
January 2011, PloS one,
Reza Lashgari, and Fereshteh Motamedi, and Seyed-Mohammad Noorbakhsh, and Saleh Zahedi-Asl, and Alireza Komaki, and Siamak Shahidi, and Abbas Haghparast
January 2015, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP,
Reza Lashgari, and Fereshteh Motamedi, and Seyed-Mohammad Noorbakhsh, and Saleh Zahedi-Asl, and Alireza Komaki, and Siamak Shahidi, and Abbas Haghparast
November 2014, Journal of neurophysiology,
Reza Lashgari, and Fereshteh Motamedi, and Seyed-Mohammad Noorbakhsh, and Saleh Zahedi-Asl, and Alireza Komaki, and Siamak Shahidi, and Abbas Haghparast
January 2007, Neuropharmacology,
Copied contents to your clipboard!